Ian D. Wall
GlaxoSmithKline (United Kingdom) · 48 works · 2,915 citations · h-index 22
Top works
- A Critical Assessment of Docking Programs and Scoring Functions
- Exploring Ligand Stability in Protein Crystal Structures Using Binding Pose Metadynamics
- Binding Constants of Neuraminidase Inhibitors: An Investigation of the Linear Interaction Energy Method
- Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study
- The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor
- Bioinformatics and molecular modelling approaches to GPCR oligomerization
- Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening
- Design and Synthesis of a Highly Selective and In Vivo -Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of Proteins
- Crystal structures of ASK1‐inhibtor complexes provide a platform for structure‐based drug design
- Pyridine-3-carboxamides as novel CB2 agonists for analgesia
- Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit
- Ensemble Simulations and Experimental Free Energy Distributions: Evaluation and Characterization of Isoxazole Amides as SMYD3 Inhibitors
- GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family
- Optimization of Sphingosine-1-phosphate-1 Receptor Agonists: Effects of Acidic, Basic, and Zwitterionic Chemotypes on Pharmacokinetic and Pharmacodynamic Profiles
- Modeling GPCR active state conformations: The β2‐adrenergic receptor
- Optimal water networks in protein cavities with GAsol and 3D-RISM
- Mycobacterium tuberculosis Decaprenylphosphoryl-β- d -ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity
- Sensitivity of Binding Free Energy Calculations to Initial Protein Crystal Structure
- ProtoCaller: Robust Automation of Binding Free Energy Calculations
- Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors